Researchers at University of California San Diego School of Medicine, with colleagues from the ACTIV-2 trial, part of the U.S. government's response to COVID-19, investigated whether symptoms of COVID-19 recurred following a two-day symptom-free period in persons who did not receive any treatment for the disease.
Treated or not, Covid recurrence seems symptomatic for some miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
ACTG announces publication of ACTIV-2 study in Cell Reports Medicine demonstrating rapid clearance of culturable Covid following miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Casirivimab/imdevimab appeared to lower the incidence of symptomatic COVID-19 in an infected, but asymptomatic, group. Editorialists urge caution, however, in interpreting the results.
Blood-based biomarkers may predict HIV remission after stopping antiretroviral therapy eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.